Friday, August 21, 2026
21.8 C
Bengaluru

Breaking Performance Barriers

[wpfilebase tag=file id=57 tpl=download-button /]

Inside this Issue

1. LinkedIn Leadership from K. Hariram

“How to lead a team of seniors” and “importance of keeping the ego in check when giving negative feedback” are issues covered in this edition.

2. Patient Access Part-III: Future of eHealthcare – Patient Convenience by Pankaj Mehrotra

Providing patients with an integrated health solution rather than just pills, is the future of pharma.

3. e-Pharmacies Are Here to Stay by Rinkesh Shah

Only a few compliance issues remain which can easily be ironed out. The consumer will benefit from this service.

4. Personalized Learning by Gopal Kishore

Using technology to make learning personalized is both cost effective and impactful.

5. What Barcodes Can Bring to Patient Support Programmes by Amaninder S Dhillon

Barcoding medicine packs can throw up valuable data for pharma companies while enhancing patient compliance.

6. Real World Data: A Primer by Ramandish Arora, Mohit Kumar Bhutani, Richa Goyal and Mahendra Kumar Rai

Unlike experimental data, real world data is more robust in terms of predicting outcomes, once inconsistancies are weeded out.

7. To, Every New Frontline Manager by K. Hariram

An open letter to every new Frontline Manager, in verse.

Hot this week

Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?

Something remarkable has happened in the Indian pharmaceutical market....

Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?

C-Suite Executive Summary India stands at a pivotal juncture in...

Rajesh Bhogavalli has been appointed as Chief Commercial Officer of ACG Group.

With over 25 years of leadership experience across commercial...

Will President Trump’s Diktat Improve Drug Quality For Indian Patients?

Executive Summary The geopolitical landscape of pharmaceutical manufacturing is shifting...

Mounjaro is the Exceptional Growth Story: Ranks #1

The July Brand Monitor by Pharmarack shows a healthy...

Topics

Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?

Something remarkable has happened in the Indian pharmaceutical market....

Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?

C-Suite Executive Summary India stands at a pivotal juncture in...

Will President Trump’s Diktat Improve Drug Quality For Indian Patients?

Executive Summary The geopolitical landscape of pharmaceutical manufacturing is shifting...

Mounjaro is the Exceptional Growth Story: Ranks #1

The July Brand Monitor by Pharmarack shows a healthy...

Sun Pharma: In the Eye of the Storm of Ophthalmologists

The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...

Does India Need to Reinvent the Wheel on Junk Foods?

In a written reply in the Lok Sabha in...
spot_img

Related Articles

spot_imgspot_img